Phimedix Plc - INVESTORS

Phimedix Plc - HOME

About Phimedix (the "Company")

On 12th March 2020 trading commenced in the new ordinary shares of the Company following a change of name from Zibao Metals Recycling Holdings Plc, a disposal of its only subsidiary, a share capital reorganisation, share buyback, placing and new investment.

The above action was part of a process following which the Company became an AIM Rule 15 cash shell with plans to put in place a new investment policy and strategy. This strategy was updated on the 7th May 2020 whereby it was disclosed that the Company was considering opportunities related to technology and life sciences. Further news in relation to this change of focus will be disclosed in future announcements once available. For the present, the directors have not identified any investment opportunities which they have resolved to pursue.

The entire details of all the above changes can be found in a Circular dated 14th February 2020 which is attached below and also summarised in RNS announcements made on the same day with a further update announced on the 11th and 12th March 2020.

Business Description

For now, the business is described as being a cash shell as set out above in About Phimedix

INVESTORS

The Directors look forward to providing investors with future updates as they ocurr. These will be announced in accordance with the AIM Rules for Companies and until then, nothing more can be disclosed. This section will evolve as news emerges. Please also refer to the Investor Section for detailed information about the Company.

Corporate Governance

The Board of the Company recognises the importance of sound corporate governance and applies the Quoted Companies Alliance Code 2018 (QCA Code) which it believes is the most appropriate recognised governance code for companies with shares admitted to trading on AIM. It is believed that the QCA Code provides the Company with the framework to help ensure that a strong level of governance is maintained enabling the Company to embed the governance culture that exists within the organisation as part of a need to build a successful and sustainable business for all its stakeholders.

The QCA Code has ten principles of corporate governance which the Company is committed to applying within the foundations of the business. These principles are as follows:

1. Establish a strategy and business model which promotes long term value for shareholders.

2. Seek to understand and meet shareholder needs and expectations.

3. Take into account wider stakeholder and social responsibilities and their implications for long term success.

4. Embed effictive risk management, considering both opportunities and threats, throughout the organisation.

5. Maintain the Board performance based on clear and relevant objectives, seeking continuous improvement.

6. Ensure that between them, the directors have the necessary experience, skills and capabilities.

7. Evaluate Board performance based on clear and relevant objectives, seeking continuous improvement.

8. Promote a corporate culture which is based on ethical values and behavious.

9. Maintain governance structures and processes which are fit for purpose and support good decion making by the Board.

10. Communicate hoe the Company is governed and is performing by maintaining a dialogue with shareholders and other relevant stakeholders.

CONTACT

Please send an email to the Directors using this address: nelson@nexfin.org.uk

INVESTOR SECTION

This section will periodically be updated and amended as it should under the AIM Rules for companies.

The website was last updated on 7th May 2020

AIM Rule 26

In February 2007, AIM Rule 26 was introduced which stated that each AIM company must maintain a website within which the following information should be available to view free of charge:

Business Description and its investing policy if applicable.

As set out in the Home page.

Country of incorporation and its main country of operation.

Incorporated in England and Wales with England as its country of operations

Details of any other exchanges or trading platforms on which the company has applied or agreed to have its securities traded or admitted

None

Advisers

Nominated Adviser (NOMAD): Spark Advisory Partners Limited, 5 St John's Lane, London EC1M 4BH

Corporate Stockbroker: SI Capital. London Office: 13 Hanover Square, London W1S 1HN

Ordinary Shares in Issue

34,400,481 ordinary shares of £0.001

Warrants in Issue

16,959,615 exercisable at 0.1p each, within 12 months of issue

Restrictions over shares

None

Percentage of shares in public hands

98%

Significant Shareholders above 3% excluding directors as shown on the shareholder register

Shareholder	Ordinary £0.001 shares	Percentage of ordinary shares in issue
JIM Nominees Ltd Des: JARVIS	13,297,264	38.7%
Spreadex Limited	9,226,057	26.8%
Ferlim Nominees Ltd Des: Pooled	4,884,326	14.2%
The Bank of New York Nominees Ltd Des: 672938	3,256,250	9.5%
Barnard Nominees Ltd Des: OBOMEX	2,577,884	7.5%

Of the above shareholders, any underlying shareholders as disclosed to the company

Mr Ali Mortazavi	4,645,114	13.50%
Mr David Norwood	2,891,923	8.41%
Spreadex Ltd under spreadbet arrangement for Mr Christopher Potts	9,226,057	26.82%
Mr Alex Snow	4,869,936	14.20%
Mr Steven Myers	2,659,230	7.70%
Mr Steven Metcalf	1,355,770	3.94%
Mr Adam Reynolds	1,355,770	3.94%

Directors Share and Warrant interests

Director	Ordinary £0.001 Shares	Warrants at £0.001
Nicholas Nelson	678,365*	339,182*
Ajay Rajpal	None	None

*Held in a SIPP under WB Nominees Ltd

Directors summaries and duties

The principal duties of the two directors below is to maintain the Company's reporting and disclosure obligation. As time progresses, their duties will extend to the implementation of an acquisition or investing policy.

The Directors are committed to following the QCA guidlines on corporate governance which will include the installation of the various corporate governance committees.

The Company is subject to the UK City Code on Takeovers and Mergers.

Ajay Kumar Rajpal, age 50. Director

A Chartered Accountant qualifying with Arthur Andersen and a member of the Institute of Chartered Accountants in England and Wales. Mr Rajpal has a background in cross-border mergers and acquisitions, financial management and corporate recovery.

Nicholas Christian Paul Nelson, age 55. Director

Commenced his career as a securities dealer on the floor of the London Stock Exchange in 1985. This developed into a 13 year career in investment management. In 1998 he moved into the Financial PR industry and over 14 years, handled the corporate communications matters to smaller quoted companies operating in multiple sectors. During this period, Nicholas handled the Financial PR aspects of some 150 AIM and NEX IPOs. He has held directorships with six AIM-quoted companies and two NEX Exchange companies and is currently Chief Executives of NEX listed SulNOx Group Plc. Nicholas has considerable hands on experience of all day to day matters relating to shareholder reporting, PLC management, sales and strategy.

Constitutional and Shareholder Documents

Constitutional Documents

File: IncorporationDocs2013.pdf

File: Admission_DocumentJune2014.pdf

File: ZibaoMetals-CircularandNoticeofGM14Feb2020.pdf

File: NameChangeCertificatetoPhimedix9March2020.pdf

File: PhimedixNewArticlesofAssociationMarch2020.pdf

Annual Reports and Accounts

File: AnnualReporttoMarch2014.pdf

File: AnnualReporttoMarch2015.pdf

File: AnnualReporttoMarch2016.pdf

File: AnnualReporttoMarch2017.pdf